Minimally Invasive Surgical Instruments Market Report, 2026

[Healthcare News]

The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682

The key players in this market are Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), HOYA Corporation (Japan), Surgical Innovations Group plc (UK), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Applied Medical Resources Corporation (US), KLS Martin Group (Germany), Scanlan International, Inc. (US), Wexler Surgical (US), STRAUSS SURGICAL (US), AMNOTEC International Medical GmbH (Germany), EndoMed Systems GmbH (Germany), TROKAMED GmbH (Germany), and Surgical Holdings (UK).

Handheld instruments accounted for the largest share of the minimally invasive surgical instruments market.

Handheld instruments accounted for the largest share of the MIS instruments market size in 2018. The large share of this segment can be attributed to the increasing number of surgical procedures and the development of high-dexterity, low-cost articulating laparoscopic handheld surgical instruments.

The cardiothoracic surgery segment accounted for the largest share of the market.

The cardiothoracic surgery segment accounted for the largest share of the MIS instruments market share in 2018. The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.

Opportunity: Emerging markets

Emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the minimally invasive surgical instruments market to focus on emerging countries.

North America accounted for the largest share of the market

The minimally invasive surgical instruments market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the global MIS instruments market, closely followed by Europe. Factors such as the large volume of surgical procedures in North American countries due to early diagnosis and treatment, high cost of procedures as compared to developing regions, increasing number of surgical centers, and growing adoption of minimally invasive surgical techniques are driving the growth of the North American market during the forecast period.

Request For Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=682

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the presence of a large patient pool undergoing surgical treatments, growing awareness about modern surgical instruments and techniques, and the implementation of various initiatives to reduce the rising healthcare expenditure in the Asia Pacific are the major growth drivers for this regional market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[e-mail]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/minimally-invasiv...
Press Release: https://www.prnewswire.com/news-releases/minimally-invasive-surgica...